Hence, we hypothesised that the inhibition of HPV E7 in cervical cancer cells would lead to restored Rb function, causing reduced E2F activity, and thus diminished Kpnβ1 and Kpnα2 promoter activities. The gene discussed is KPNB1; the disease is cervical cancer.